Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Alan J. Concannon"'
Autor:
Kerry Atkinson, P. Tutschka, K. Downs, Alan J. Concannon, Isadore Brodsky, Jeff Szer, N. Kapoor, J. C. Biggs, P. Crilley, Edward A. Copelan, David Topolsky, B. Avalos, Anthony J. Dodds, S Bulova
Publikováno v:
Scopus-Elsevier
One hundred fifteen patients with chronic myelocytic leukemia (CML) were administered busulphan 4 mg/kg for 4 days and cyclophosphamide 60 mg/kg on each of 2 days (BuCy2) followed by allogeneic bone marrow transplantation from histocompatible sibling
Autor:
Marie Golenia, James C. Biggs, Kerry Atkinson, K. Downs, Gai Marshall, Alan J. Concannon, Anthony J. Dodds
Publikováno v:
British Journal of Haematology. 79:57-62
Ganciclovir was given prophylactically to 25 patients receiving allogeneic bone marrow transplants for haematological malignancy. Patients who were seropositive for cytomegalovirus (CMV) pre-transplant were given ganciclovir both pre- and post-transp
Publikováno v:
British Journal of Haematology. 76:128-134
Summary. Sequential changes in serum erythropoietin (sEPO) levels were measured by radioimmunoassay in six patients receiving autologous rescue (AR) and 11 patients receiving an allogeneic bone marrow transplant (BMT) for malignant disease. Longitudi
Publikováno v:
Pathology. 22:206-211
In 4 years (1984-1987), 183 bone marrow examinations were performed on 155 human immunodeficiency virus (HIV) antibody positive patients. One hundred and fifty three had category IV AIDS. One-third of the marrows yielded specific information. This in
Publikováno v:
Pathology. 30:318-320
Summary We present two cases of bone marrow necrosis not associated with malignancy, infection or sickle cell disease. The first case, a 28 year old woman with the antiphospholipid syndrome and a factor V Leiden abnormality, suffered an illness chara
Autor:
Ian Nivison-Smith, Sam Milliken, Alan J. Concannon, K. Downs, Kerry Atkinson, Anthony J. Dodds
Publikováno v:
Bone marrow transplantation. 21(7)
A comparison was made of the pattern of interstitial pneumonitis (IP) following allogeneic bone marrow transplantation before and after the introduction of ganciclovir prophylaxis to minimize the risk of cytomegalovirus (CMV) disease in the St Vincen
Publikováno v:
Australian and New Zealand journal of medicine. 26(1)
Background : HLA-identical sibling bone marrow transplantation is an accepted treatment for patients with acute myeloid leukaemia (AML) and chronic myeloid leukaemia (CML). We have recently reported improving results in HLA-identical sibling transpla
Autor:
D. Rosenfeld, Keith Fay, Michael Harvey, Mark Harris, J. Song, D. Lind, Kerry Atkinson, V. Quigley, Sam Milliken, Anthony J. Dodds, Steve Flecknoe-Brown, D. Flattery, T. Hawkins, K. Downs, Adèle C. Green, Alan J. Concannon, J. Rutovitz, R. McKinley
Publikováno v:
Australian and New Zealand journal of medicine. 25(5)
Background: Lengthy remission or cure has remained elusive for patients with many of the common haematological malignancies. Thus high dose chemotherapy followed by autologous haemopoietic stem cell transplantation is being increasingly utilised in t
Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney
Autor:
F. Wilson, Kerry Atkinson, K. Downs, Alan J. Concannon, Anthony J. Dodds, D. Staniforth, Glenn M. Marshall, Sam Milliken
Publikováno v:
Australian and New Zealand journal of medicine. 23(5)
Background: Only 30% of patients with leukaemia have an HLA-compatible family member able to act as a marrow donor. The recent development of volunteer bone marrow donor registries has supplied HLA-matched donors for a number of such individuals. Aim
Autor:
F. Wilson, K. Downs, Glenn M. Marshall, M. Ashby, Graeme Morgan, Anthony J. Dodds, S. Young, Sam Milliken, J. Harkness, Alan J. Concannon, J. C. Biggs, Kerry Atkinson
Publikováno v:
Australian and New Zealand journal of medicine. 23(2)
During the years 1981-90 inclusive 227 patients with haematological malignancy received an HLA-identical sibling first transplant at St Vincent's Hospital, Sydney. Recipients with acute leukaemia in first remission or chronic myeloid leukaemia in fir